Lin, M., Chen, Y., Jin, Y., Hu, X., & Zhang, J. (2020). Comparative Overall Survival of CDK4/6 Inhibitors Plus Endocrine Therapy vs. Endocrine Therapy Alone for Hormone receptor-positive, HER2-negative metastatic breast cancer. J Cancer.

Lin, Mingxi, Yang Chen, Yizi Jin, Xichun Hu, a Jian Zhang. "Comparative Overall Survival of CDK4/6 Inhibitors Plus Endocrine Therapy Vs. Endocrine Therapy Alone for Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer." J Cancer 2020.

Lin, Mingxi, et al. "Comparative Overall Survival of CDK4/6 Inhibitors Plus Endocrine Therapy Vs. Endocrine Therapy Alone for Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer." J Cancer 2020.